Navidea biopharmaceuticals to host second quarter 2021 earnings conference call and business update

Dublin, ohio--(business wire)--navidea biopharmaceuticals, inc. (nyse american: navb) (“navidea” or the “company”), a company focused on the development of precision immunodiagnostic agents and immunotherapeutics, today announced it will host a conference call and webcast on wednesday, august 11, 2021 at 5:00 p.m. (edt) to discuss financial results and corporate developments for the second quarter ended june 30, 2021. jed latkin, chief executive officer, dr. michael rosol, chief medical officer
NAVB Ratings Summary
NAVB Quant Ranking